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Edited by Vladimir SkulachevAbstract Overexpression of TGFb inducible early gene
(TIEG1) mimics TGFb action and induces apoptosis. In this
study, we found that TIEG1 was signiﬁcantly up-regulated during
apoptosis induced by homoharringtonine or velcade. Overexpres-
sion of TIEG1 could induce apoptosis in K562 cells and promote
apoptosis induced by HHT or velcade. TIEG1-induced apoptosis
was shown to involve Bax and Bim up-regulation, Bcl-2 and Bcl-
XL down-regulation, release of cytochrome c from mitochondria
into the cytosol, activation of caspase 3 and disruption of the
mitochondrial membrane potential (DWm). We concluded that
TIEG1 is a key regulator which induces and promotes apoptosis
through the mitochondrial apoptotic pathway.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Mitochondrial pathway1. Introduction
TGFb inducible early gene (TIEG1), TIEG2 and TIEG3
constitute a new subfamily of transforming growth factor-b-
inducible Sp1-like proteins [1,2]. TIEG1, TIEG2 and TIEG3
were immediately induced by TGFb [3–5]. TIEG1 was also in-
duced by nitric oxide [6], 15-hydroxy-eicosatetraenoic acid [7]
and doxazosin [8]. We previously reported that TIEG1 mRNA
was signiﬁcantly induced by homoharringtonine (HHT) [9]. It
was reported that overexpression of TIEG1 mimiced TGFb
action and induced apoptosis in human osteoblast cells, pan-
creatic carcinoma cells, epithelial and liver cancer cells [10–
13]. However, so far, there have been no reports as to whether
TIEG1 can induce apoptosis through mitochondrial apoptotic
pathway.
In this study, for the ﬁrst time, we found that human TIEG1
or mouse TIEG1 was signiﬁcantly up-regulated during apopto-
sis in the human K562 leukemia cells or mouse B16 melanomaAbbreviations: HHT, homoharringtonine; DWm, mitochondrial mem-
brane potential; TIEG1, TGFb inducible early gene; PMSF, phenyl-
methylsulphonyl ﬂuoride
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doi:10.1016/j.febslet.2007.07.008cells induced by HHT, human TIEG1 was also signiﬁcantly up-
regulated during apoptosis in theK562 cells induced by velcade.
Overexpression of TIEG1 could induce apoptosis in K562 cells
and promote apoptosis induced by HHT and velcade. TIEG1-
induced apoptosis was shown to involve Bax and Bim up-regu-
lation, Bcl-2 and Bcl-XL down-regulation, release of cyto-
chrome c from mitochondria, activation of caspase 3 and
destroying the mitochondrial membrane potential (DWm).
We concluded that TIEG1 was up-regulated during apopto-
sis induced by HHT or velcade not only in human cells but also
in mouse cells. TIEG1 is a key regulator which can induce and
promote apoptosis through mitochondrial apoptotic pathway.2. Materials and methods
2.1. Cell culture, transfection and plasmids
Human K562 leukemia cells and mouse B16 melanoma cells were
cultured in RPMI 1640 medium containing 10% fetal bovine serum
in 95% air and 5% CO2 at 37 C. For the experiment, K562 cells were
incubated with 10 nM velcade (was kindly provided by Dr. Hua Yan
of Ruijin Hospital, Shanghai, China) or 10 lM HHT (Beijing Union
Pharmaceutical Factory, Beijing, China) or RPMI 1640 medium alone
for 24 h and 48 h, B16 cells were incubated with 36 lMHHT or RPMI
1640 medium alone for 24 h and 48 h.
TIEG1 overexpression vector with the amino-terminal FLAG epi-
tope-tagged (pcDNA4/TO-TIEG) or its control empty vector
(pcDNA4/TO) was transfected into k562 cells by using Lipofectamine
2000 (GIBCO BRL).
2.2. Detection of DNA fragmentation
The total cellular DNA was extracted from cells by the method de-
scribed by Slin and Staﬀord with some slight modiﬁcations [14]. In
brief, cells were washed and lysed overnight at 37 C in lysis buﬀer con-
taining Tris–HCl 10 mM (pH 8.0), edetic acid 10 mM, 0.4% sodium
dodecylsulfate, and proteinase K 100 mg/l. Subsequently cells were
treated with 0.5 lg/ml RNase A for 2 h. The genomic DNA was ex-
tracted by phenol–chloroformisoamyl alcohol extraction. Electropho-
resis was performed on 2.0% agarose gel. The DNA was visualized
by UV illumination.
2.3. Morphological observation of apoptotic cells
K562 cells or B16 cells after exposure to conditions indicated were
centrifuged and washed with PBS, ﬁxed with 4% paraformaldehyde
and stained with Hoechst 33258 (5 lg/ml, Sigma) for 15 min, detect
apoptosis by ﬂuorescence microscopy.
2.4. RNA isolation
Total RNA from cells was extracted according to the original
Chomczynski method with slight modiﬁcations [15]. Cells wereblished by Elsevier B.V. All rights reserved.
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toethanol. After centrifugation, supernatant was extracted with phe-
nol:chloroform (1:1) twice and acidic phenol:chloroform (5:1) once.
The RNA from aqueous phase was precipitated by cold isopropanol
and dissolved in deionized H2O. Messenger RNAs were puriﬁed using
an Oligotex-dT mRNA Midi Kit (Qiagen, Inc., Carlsbad, CA).2.5. Detection and analysis of microarray
The 14218 microarray consists of 14218 human full-length or partial
complementary DNAs, the 8000 microarray consists of 8000 mouse
full-length or partial complementary DNAs. All microarrays were pro-
vided by United Gene Holdings, Ltd. (1111 Zhongshan Bei Er Road,
Shanghai, China). Microarrays were hybridized and scanned as previ-
ously described [9]. Genes were identiﬁed as diﬀerentially expressed if
the ratio of Cy5/Cy3 was >2 or <0.5.2.6. Reverse transcription-PCR
Total RNA was extracted from cells with TRIzol reagent (Invitrogen
Life Technologies, Inc.). The reverse transcription reaction was per-
formed using the Superscript First-Strand Synthesis System (Invitrogen
Life Technologies, Inc.). The newly synthesized cDNA was ampliﬁed
by PCR. Human TIEG1 primer (5 0-ACTGCGGAGGAAAGAA-
TGGA-30; 5 0-CTGGGAGGAGTGCTGGGAAC-3 0), mouse TIEG1
primer (5 0-CGTCTAGTGTCTCAGTGCTC-3 0; 5 0-CTCTTTGAAA-
GGAGTGGC-3 0). Human GAPDH primer (5 0-GCCAAAAGGGT-
CATCATCTC-3 0; 5 0-GTAGAGGCAGGGATGATGTTC-3 0) and
mouse GAPDH primer (5 0-ACAGCCGCATCTTCTTGTGCAGTG-
3 0; 5 0-GGCCTTGACTGTGCCGTTGAATTT-3 0) were used as an
internal control. Ampliﬁcation cycles were: 94 C for 3 min, then 33 cy-
cles at 94 C for 1 min, 56 C for 1 min, 72 C for 1.5 min, followed by
72 C for 10 min. Aliquots of PCR product were electrophoresed on
1.5% agarose gels, and PCR fragments were visualized by ethidium bro-
mide staining.
2.7. Quantiﬁcation of apoptosis
Cells were stained with Hoechst 33258 and then observed under a
ﬂuorescence microscope. Apoptotic cells with condensed or frag-
mented nuclei were easily distinguished from normal cells with intact
nuclei. Quantiﬁcation of apoptosis was determined by counting the
number of apoptotic cells: six randomly chosen ﬁelds of view were ob-
served after exposure to the conditions indicated, with a minimum
number of 500 cells scored in each condition.
2.8. Preparation for cytosolic and mitochondrial fractions
The cells were washed and resuspended in buﬀer A (250 mM su-
crose, 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 1 mM EDTA,
1 mM dithiothreitol, 0.1 mM phenylmethylsulphonyl ﬂuoride (PMSF),
1 lg/ml aprotinin, 1 lg/ml leupeptin, 10 mM HEPES–KOH, pH 7.4).
After 30 min incubation on ice, cells were homogenized and centri-
fuged at 700 · g for 10 min. The supernatant was collected, centrifuged
at 10,000 · g for 25 min, the supernatant was the cytosolic fraction and
the pellets were resuspended in 50 ll of buﬀer A supplemented with
5 ll of buﬀer B (10% Triton X-100 and 10% DMSO in Buﬀer A), cen-
trifuged at 5000 · g and the resulting supernatant was the mitochon-
drial fraction.
2.9. Western blot analysis
To prepare the whole-cell extract, cells were washed, lysed in cold
TNT buﬀer (20 mM Tris–HCl (pH 7.4), 200 mM NaCl, 1% Triton
X-100, 1 mM PMSF, and 1% aprotinin) for 45 min. The lysates were
centrifuged at 12,000 · g for 40 min at 4 C, the supernatant (50 lg
of protein) were resolved by SDS–PAGE. Proteins were transferred
to nitrocellulose. The membrane was incubated in blocking solution
consisting of 5% powered milk in TBST (10 mM Tris–HCl (pH 8.0),
150 mM NaCl, and 0.1% Tween 20) for 1 h, then immunoblotted with
TIEG1 antibody, Bcl-2 antibody, Bax antibody, Bcl-XL antibody
(Santa Cruz Biotechnology, Inc.), cytochrome c antibody (BD Biosci-
ences), COX-4 antibody (Molecular Probes), Bim antibody (Imgenex),
cleaved caspase-3 antibody (Cell Signaling Technology, Inc.), anti-
FLAG M2 antibody (Sigma), antitubulin antibody (Sigma–Aldrich).
Detection by enzyme-linked chemiluminescence was performed
according to the manufacturer’s protocol (ECL; Amersham Pharmacia
Biotech).2.10. siRNA preparation and transfection
TIEG1 siRNA is a pool of 3 target-speciﬁc 19 nt siRNAs designed to
knock down TIEG1 expression. The siRNA was synthesized by Shang-
hai GeneChem (Zhangjiang, Shanghai). The cells in the exponential
phase of growth were seeded in 6-well plates at a concentration of
5 · 105 cells/well. After incubation for 24 h, the cells were transfected
with siRNA (100 nmol/l) and Lipofectamine 2000 (Invitrogen Life
Technologies, USA) according to the manufacturer’s protocol. Silenc-
ing was examined 48 h after transfection. The control cells were treated
with non-targeting siRNA.
2.11. Determination of DWm
JC-1 staining was performed according to the manufacture’s instruc-
tions (Molecular Probes). Brieﬂy, cells were collected and washed with
PBS. Cells were then incubated with 10 lg/ml of JC-1 in warm PBS for
15 min. After washing with PBS, the cells were analyzed using a ﬂow
cytometry (Becton Dickinson). Red and green ﬂuorescence were ex-
pressed as percentages of total gated cells.
2.12. Statistical analysis
Data shown represent means ± standard deviation (S.D.). Statistical
analyses for detection of signiﬁcant diﬀerences between the control and
experimental groups were carried out using Student’s t-test.3. Results
3.1. Apoptosis in human K562 leukemia cells induced by HHT
and velcade or in mouse B16 melanoma cells induced by
HHT
Apoptosis in human K562 leukemia cells or in mouse B16
melanoma cells induced by HHT or velcade was examined
(Fig. 1A–C). DNA agarose gel electrophoresis showed that
K562 cells and B16 cells presented typical DNA ladder pat-
terns of apoptosis after treatment with 10 lM or 36 lM
HHT for 24 h and 48 h. K562 cells presented a typical DNA
ladder pattern of apoptosis after treatment with 10 nM velcade
for 24 h and 48 h.
As shown with Hoechst-33258 staining, control K562 cells
and B16 cells that were not submitted to HHT or velcade treat-
ment did not exhibit chromatin condensation. By contrast,
dense and thin crown of nuclear coloration, typical of chroma-
tin condensation, could be observed in the HHT- or velcade-
treated cells at 24 h or 48 h (Fig. 1E). We found that although
several nuclei still displayed normal morphology, most of the
cells exhibited very intense staining of condensed and frag-
mented chromatin. These evidences clearly showed that HHT
could induce apoptosis in K562 cells and B16 cells, velcade
could induce apoptosis in K562 cells.
3.2. cDNA microarray analysis
In order to identify apoptosis-responsive genes, RNA was
isolated from K562 cells and B16 cells treated with HHT for
6 h, 24 h and subjected to microarray hybridization. Interest-
ingly, TIEG1 was the most signiﬁcant up-regulated gene dur-
ing apoptosis both in K562 cells and in B16 cells, which was
observed to be increased by 6–8 folds.
3.3. TIEG1 increased in apoptotic K562 cells induced by HHT,
velcade and in apoptotic B16 cells induced by HHT
To conﬁrm the results obtained from the microarray hybrid-
ization and to detect if TIEG1 was up-regulated by velcade,
we performed Reverse Transcription-PCR and Western blot.
As shown in Fig. 1F and G, TIEG1 mRNA and protein
increased signiﬁcantly in apoptotic K562 cells induced by
3828 W. Jin et al. / FEBS Letters 581 (2007) 3826–3832HHT, velcade and in apoptotic B16 cells induced by HHT.
Expression patterns of TIEG1 correlated with the microarray
results.
3.4. Overexpression of TIEG1 could induce apoptosis in K562
cells
To detect the overexpressed TIEG1 in K562 cells, we per-
formed Reverse Transcription-PCR and Western blot. As
shown in Fig. 3C and D, TIEG1 mRNA and protein increased
signiﬁcantly in K562 cells after transfection with pcDNA4/TO-
TIEG1 for 24 h and 48 h. DNA agarose gel electrophoresis
showed that K562 cells presented typical DNA ladder patterns
of apoptosis after transfection with pcDNA4/TO-TIEG1 for
24 h and 48 h (Fig. 1D). As shown with Hoechst-33258 stain-
ing, control K562 cells did not exhibit chromatin condensa-Fig. 1. Patterns of DNA fragmentation during apoptosis in K562 cells indu
induced by HHT (C). (A) 1: 100 bp DNA Ladder Marker; 2: untreated cells;
untreated cells; 2: velcade 10 nM, 6 h; 3: velcade 10 nM, 24 h; 4: velcade 10 nM
cells; 2: HHT 36 lM, 6 h; 3: HHT 36 lM, 24 h; 4: HHT 36 lM, 48 h; 5: 100 b
with control empty vector pcDNA4/TO 48 h; 3: K562 cells transfected with
TIEG1, 24 h; 5: K562 cells transfected with pcDNA4/TO-TIEG1, 48 h; 6:
apoptotic changes in B16 cells induced by HHT for 24 h, 48 h, in K562 cells i
cells transfected with TIEG1 expression vector pcDNA4/TO-TIEG1 or its
treated with HHT or velcade for 24 h, 48 h. (F) TIEG1 mRNA and protein (
and apoptotic B16 cells induced by HHT (c). (a) 1: untreated K562 cells; 2: H
velcade 10 nM, 24 h; 3: velcade 10 nM, 48 h; (c) 1: untreated B16 cells; 2: Htion. By contrast, dense and thin crown of nuclear
coloration, typical of chromatin condensation, could be ob-
served in the cells transfected with pcDNA4/TO-TIEG1 for
24 h and 48 h (Fig. 1E).
3.5. TIEG1 promoted apoptosis induced by HHT and velcade,
inhibition of TIEG1 by siRNA attenuated HHT- and
velcade-induced apoptosis
To further examine the role of TIEG1 in apoptosis induced
by HHT and velcade, K562 cells were transfected with
pcDNA4/TO-TIEG1 (Fig. 3C and D) or siRNA targeting
TIEG1 (Fig. 3A and B) for 8 h, then treated with 10 lM
HHT or 10 nM velcade for 24 h and 48 h. Percentages of apop-
totic cells were assessed by counting the cells stained with Hoe-
chst 33258. As shown in Fig. 2A and B, the overexpression ofced by HHT (A), velcade (B), overexpressed TIEG1 (D), in B16 cells
3: HHT 10 lM, 3 h; 4: HHT 10 lM, 24 h; 5: HHT 10 lM, 48 h. (B) 1:
, 48 h; 5: Lambda DNA/Eco130I (StyI) marker (bp). (C) 1: untreated
p DNA Ladder Marker. (D) 1: untreated cells; 2: K562 cells transfected
pcDNA4/TO-TIEG1, 6 h; 4: K562 cells transfected with pcDNA4/TO-
Lambda DNA/Eco130I (StyI) marker (bp). (E) Photomicrograph of
nduced by HHT, velcade or overexpressed TIEG1 for 24 h, 48 h, K562
control vector pcDNA4/TO, transfected or untransfected K562 cells
G) increased in apoptotic K562 cells induced by HHT (a), Velcade (b)
HT 10 lM, 24 h; 3: HHT 10 lM, 48 h; (b) 1: untreated K562 cells; 2:
HT 36 lM, 24 h; 3: HHT 36 lM, 48 h.
Fig. 1 (continued)
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Fig. 2. Overexpression of TIEG1 promoted HHT- and velcade-induced apoptosis, inhibition of TIEG1 by siRNA attenuated HHT- and velcade-
induced apoptosis. K562 cells were transfected with pcDNA4/TO-TIEG1 or siRNA targeting TIEG1 (A, B), after 8 h, transfected or untransfected
k562 cells were treated by HHT or velcade. Apoptotic cells were measured by counting the cells after staining with Hoechst 33258. Diﬀerent treated
cells was compared with parental K562 cells (*P < 0.01). (A) K562 cells transfected with pcDNA4/TO-TIEG1 or TIEG1-siRNA treated by HHT. (B)
K562 cells transfected with pcDNA4/TO-TIEG1 or TIEG1-siRNA treated by velcade.
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proteins, caspase 3 and cytochrome c
In order to determine whether Bcl-2 family proteins were in-
volved in the apoptotic process induced by TIEG1, Bcl-2 fam-
ily pro-apoptotic proteins, including Bim, Bax and anti-
apoptotic proteins, including Bcl-2 and Bcl-XL, were detected
by Western blot. As shown in Fig. 3E, TIEG1 could increase
the expression of Bax and Bim proteis and inhibit the expres-
sion of Bcl-2 and Bcl-Xl proteins.
As shown in Fig. 3F, the cleaved caspase 3 was activated
after transfection with pcDNA4/TO-TIEG1 for 24 h and
48 h. As shown in Fig. 3G, the cytosolic and mitochondrial
fractions of TIEG1-overexpressed cells were detected by
immunoblotting with cytochrome c antibody. Release of cyto-
chrome c from mitochondria into cytosol increased signiﬁ-
cantly in pcDNA4/TO-TIEG1 cells at 48 h compared with
pcDNA4/TO cells.
3.7. Eﬀect of TIEG1 on DWm
To study the eﬀect of TIEG1 on mitochondrial apoptotic
events, we examined changes of DWm using JC-1 staining in
K562 cells transfected with pcDNA4/TO-TIEG1 for 8 h, 24 h
and 48 h. Fig. 4 showed that overexpression of TIEG1 resulted
in signiﬁcant reduction in DWm.4. Discussion
In this study, our experiments showed that HHT could in-
duce apoptosis in K562 cells and B16 cells, velcade could in-
duce apoptosis in K562 cells. During these apoptosis, TIEG1
mRNA and protein increased signiﬁcantly. To further elucid-
ade the contribution of TIEG1 in mediating apoptosis induced
by HHT and velcade, we overexpressed TIEG1 in K562 cells
and found that overexpression of TIEG1 could induce apopto-
sis. We also found that overexpression or inhibition of TIEG1
signiﬁcantly promoted or attenuated HHT- or velcade-induced
apoptosis. From these data, we identiﬁed apoptosis induced by
HHT or velcade was TIEG1-dependent and TIEG1 was a key
factor in apoptosis.
Apoptosis can be initiated via two alternative signal path-
ways: the death receptor-mediated ‘‘extrinsic apoptotic path-
way’’ and the mitochondrion-mediated ‘‘intrinsic apoptotic
pathway [16,17].’’ Mitochondria plays a critical role in the
regulation of various apoptotic processes including drug-in-
duced apoptosis [18]. The mitochondrial death pathway is
controlled by the members of the Bcl-2 family. The Bcl-2
family consists of pro-apoptotic and anti-apoptotic members
[19]. During apoptosis, Bcl-2 family pro-apoptotic proteins,
including Bim, Bax and Bid, can translocate to the outer
Fig. 3. Eﬀect of TIEG1 on the expression levels of the Bcl-2 family proteins, caspase 3 and cytochrome c. (A) RT-PCR for TIEG1 mRNA in control
K562 cells or TIEG1-siRNA K562 cells. (B) Western blot assay for TIEG1 protein in control K562 cells or TIEG1-siRNA K562 cells. (C) RT-PCR
for TIEG1 mRNA in control K562 cells or TIEG1-overexpressed K562 cells. (D) Western blot assay for TIEG1 protein in control K562 cells or
TIEG1-overexpressed K562 cells. (E) Eﬀect of overexpressed TIEG1 on the expression of Bcl-2 family proteins. (F) Eﬀect of overexpressed TIEG1
on the expression of cleaved caspase 3. (G) Eﬀect of overexpressed TIEG1 on the expression of cytochrome c. From (A) to (B), 1: K562 cells
transfected with pcDNA4/TO; 2: K562 cells transfected with pcDNA4/TO-TIEG1; 3: K562 cells co-transfected with pcDNA4/TO-TIEG1 and non-
targeting siRNA; 4: K562 cells co-transfected with pcDNA4/TO-TIEG1 and siRNA targeting TIEG1. From (C) to (G), 1: Control K562 cells; 2:
K562 cells transfected with pcDNA4/TO; 3: K562 cells transfected with pcDNA4/TO-TIEG1.
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totic factors and induce apoptosis. Bcl-2 family anti-apoptotic
proteins, including Bcl-2 and Bcl-XL, sequestered in mito-pcDNA4/TO-TIEG1
pcDNA4/TO




















Fig. 4. Loss of DWm in K562 cells transfected with TIEG1. K562 cells
were transfected with pcDNA4/TO-TIEG1 or the control empty vector
pcDNA4/TO; the DWm was measured as described in Section 2.
Results in transfected cells are expressed as a percent of parental K562
cells (*P < 0.01).chondria, inhibit the release of pro-apoptotic factors and pre-
vent apoptosis. When interacting with activated pro-apoptotic
proteins, the anti-apoptotic proteins lose inhibiting ability of
pro-apoptotic factors’ release, and again promote apoptosis.
Alteration in the levels of anti- and pro-apoptotic Bcl-2 fam-
ily proteins inﬂuences apoptosis [20], and causes the loss of
mitochondrial membrane potential (DWm), release of cyto-
chrome c from the mitochondrial intermembrane space to-
ward the cytosol and proteolytic activation of caspase 9
and 3 [21].
In this experiment, overexpressed TIEG1 increased the level
of the pro-apoptotic proteins Bax and Bim, decreased the level
of the anti-apoptotic proteins Bcl-2 and Bcl-XL. This result
indicated that TIEG1 induced apoptosis in K562 cells by mod-
ulating Bcl-2 family proteins activity. Results also demon-
strated that cytochrome c was released from mitochondria
into cytosol in TIEG1 overexpressed cells, indicating that casp-
ases are partially responsible and this eﬀect was accompanied
by the increase of cleaved caspase 3 and destroying the
DWm. These data indicated that TIEG1 induced apoptosis
via mitochondrial pathway.
3832 W. Jin et al. / FEBS Letters 581 (2007) 3826–3832In conclusion, we demonstrated that TIEG1 was signiﬁ-
cantly up-regulated during apoptosis induced by HHT or vel-
cade. Overexpression of TIEG1 could induce apoptosis in
K562 cells and in return, promoted apoptosis induced by
HHT or velcade. TIEG1-induced mitochondrial dysfunction
resulted in the reduction of DWm accompanied by the release
of cytochrome c and caspase 3 activation.
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